William L. McGinnis - Concepedia

Author

William L. McGinnis

Also Known As

W L McGinnis, W McGinnis, W. L. McGinnis, W. McGinnis, W.L. McGinnis, William L McGinnis, William L. McGinnis, William McGinnis

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Iowa Oncology Research Association Community Cancer Center CHI Health Creighton University Medical Center - Bergan Mercy Community Hospital

About

William L. McGinnis is an author at Mayo Clinic specializing in medicine, radiation therapy, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	316
2	Health Sciences	4	4	246
3	Radiation Medicine	3	3	200
4	Cancer Therapeutics	3	3	114
5	Surgical Oncology	1	1	49

William L. McGinnis

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The Outcome of Combined-Modality Therapy for Stage III Non–Small-Cell Lung Cancer in the Elderly Steven E. Schild, Philip J. Stella, Susan M. Geyer, Journal of Clinical Oncology	2003	224
Thoracic Radiation Therapy Alone Compared with Combined Chemoradiotherapy for Locally Unresectable Non-Small Cell Lung Cancer Roscoe F. Morton, James R. Jett, William L. McGinnis, Annals of Internal Medicine	1991	190
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-? in the treatment of patients with newly diagnosed high-grade glioma Jan C. Buckner, Paula J. Schomberg, William L. McGinnis, Cancer	2001	138
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer Steven E. Schild, William L. McGinnis, David L. Graham, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineConcurrent ChemotherapyClinical Radiation Oncology	2006	132
Cheyne-Stokes Respiration Presenting as Sleep Apnea Syndrome: Clinical and Polysomnographic Features William T. Dowdell, Shahrokh Javaheri, William L. McGinnis American Review of Respiratory Disease	1990	98
Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer 1 1This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Additional participating institutions included Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA; Meritcare Hospital CCOP, Fargo, ND; Sioux Community Cancer Consortium, Sioux Falls, SD; Geisinger Clinical Oncology Program, Danville, PA (Suresh Nair, M.D.); Rapid City Regional Oncology Group, Rapid City, SD (Larry P. Ebbert, M.D.), Saskatchewan Cancer Centre, Saskatoon, Saskatchewan, Canada; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada (Maria Tria Tirona, M.D.); Scottsdale CCOP, Scottsdale, AZ (Tom R. Fitch, M.D.); Carle Cancer Center CCOP, Urbana, IL (Kendrith M. Rowland, M.D.); Medcenter One Health Systems, Bismarck, ND (Ferdinand Addo, M.D.); Altru Health Systems, Grand Forks, ND (Daniel J. Walsh, M.D.); Siouxland Hematology-Oncology Associates, Sioux City, IA (John C. Michalak, M.D.); and CentreCare Clinic, St. Cloud, MN (Harold E. Windschitl, M.D.). Steven E. Schild, Philip J. Stella, Susan M. Geyer, International Journal of Radiation OncologyBiologyPhysics	2002	93
Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly Steven E. Schild, Philip J. Stella, Burke J. Brooks, Cancer	2005	86
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study. James A. Bonner, William L. McGinnis, Philip J. Stella, PubMed	1998	68
Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non‐small cell lung cancer Lisa Sanderson Cox, Jeff A. Sloan, Christi A. Patten, Psycho-Oncology	2002	64
Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. William L. McGinnis, Charles L. Loprinzi, Steven J. Buskirk, Journal of Clinical Oncology	1997	57

Page 1